1. Wang, Xingang, Zheng, Yan, Wang, Yu. 2021. PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer. In Clinical and experimental medicine, 22, 393-402. doi:10.1007/s10238-021-00761-5. https://pubmed.ncbi.nlm.nih.gov/34554318/
2. Skingen, Vilde Eide, Hompland, Tord, Fjeldbo, Christina Sæten, Seierstad, Therese, Lyng, Heidi. 2023. Prostate cancer radiogenomics reveals proliferative gene expression programs associated with distinct MRI-based hypoxia levels. In Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 188, 109875. doi:10.1016/j.radonc.2023.109875. https://pubmed.ncbi.nlm.nih.gov/37640161/
3. Agajanian, Megan, Campeau, Anaamika, Hoover, Malachia, Klemke, Richard L, Kelber, Jonathan A. 2015. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. In PloS one, 10, e0135748. doi:10.1371/journal.pone.0135748. https://pubmed.ncbi.nlm.nih.gov/26267863/
4. Pan, Min, Yin, Xiaohui, Huang, Yi-Chuan. . Pseudopodium enriched atypical kinase 1(PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals. In Bioengineered, 12, 5045-5055. doi:10.1080/21655979.2021.1961661. https://pubmed.ncbi.nlm.nih.gov/34365903/
5. Ding, Chenbo, Tang, Wendong, Wu, Hailu, Wen, Kunming, Wu, Guoqiu. 2018. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. In Cancer letters, 442, 383-395. doi:10.1016/j.canlet.2018.11.014. https://pubmed.ncbi.nlm.nih.gov/30472186/
6. Wang, Qiuhan, Hao, Fengyun, Ning, Liang, Sun, Chong. 2024. Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAFV600E to Vemurafenib by Bim upregulation. In Histology and histopathology, 39, 1159-1165. doi:10.14670/HH-18-705. https://pubmed.ncbi.nlm.nih.gov/38284248/
7. Huang, Lanlan, Wen, Chuangyu, Yang, Xiangling, Wang, Jianping, Liu, Huanliang. 2018. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d. In Cell death & disease, 9, 271. doi:10.1038/s41419-018-0320-8. https://pubmed.ncbi.nlm.nih.gov/29449544/
8. Wang, Huawei, Lapek, John, Fujimura, Ken, Cheresh, David A, Klemke, Richard L. 2018. Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription. In Cell discovery, 4, 26. doi:10.1038/s41421-018-0024-3. https://pubmed.ncbi.nlm.nih.gov/29872538/
9. Hamalian, Sarkis, Güth, Robert, Runa, Farhana, Zervantonakis, Ioannis K, Kelber, Jonathan A. 2021. A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers. In Oncogene, 40, 5224-5235. doi:10.1038/s41388-021-01906-2. https://pubmed.ncbi.nlm.nih.gov/34239043/
智鼠故事 
